tRNA (primary)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db460c/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db460c/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db460b/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db460b/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db460a/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db460a/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4609/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4609/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4608/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4608/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4607/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4607/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4606/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4606/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4605/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4605/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4604/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4604/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4603/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4603/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4602/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4602/5b72ee9c669a911400d2f0a9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b72eef2292b6f1400db4601/5b72ee9c669a911400d2f0a9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b72eef2292b6f1400db4601/5b72ee9c669a911400d2f0a9.png"}]